203 related articles for article (PubMed ID: 5597424)
1. [The changes in the electric retinal activity during resochin treatment].
Svĕrák J; Peregrin J; Salavec M
Klin Monbl Augenheilkd; 1967 Nov; 151(5):633-40. PubMed ID: 5597424
[No Abstract] [Full Text] [Related]
2. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
3. [On the problem of chloroquine damage to the eye].
Böke W; Bäumer A; Müller-Limmroth W; Mludek M
Klin Monbl Augenheilkd; 1967 Nov; 151(5):617-33. PubMed ID: 5597423
[No Abstract] [Full Text] [Related]
4. Chloroquine retinopathy. Investigation of discrepancy between dark adaptation and electroretinographic findings in advanced stages.
Krill AE; Potts AM; Johanson CE
Am J Ophthalmol; 1971 Feb; 71(2):530-43. PubMed ID: 5547534
[No Abstract] [Full Text] [Related]
5. Drug-induced macular disease.
Potts AM
Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(6):1054-7. PubMed ID: 5971468
[No Abstract] [Full Text] [Related]
6. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
[No Abstract] [Full Text] [Related]
7. [On ocular damage caused by chloroquine].
Rinaldi G; Coslovich E; Tuvo F
Minerva Med; 1971 Feb; 62(16):766-9. PubMed ID: 5313741
[No Abstract] [Full Text] [Related]
8. Chloroquine and organic changes in the eye.
Carr RE
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:36-9. PubMed ID: 5672562
[No Abstract] [Full Text] [Related]
9. Chloroquine ocular toxicity.
Bernstein HN
Surv Ophthalmol; 1967 Oct; 12(5):415-47. PubMed ID: 4980087
[No Abstract] [Full Text] [Related]
10. Acquired color vision defects secondary to retinal drug toxicity.
Grützner P
Ophthalmologica; 1969; 158 Suppl():592-604. PubMed ID: 5307973
[No Abstract] [Full Text] [Related]
11. [Basic and clinical study on chloroquine therapy of rheumatic diseases. (2). Eye disorders due to chloroquine].
Sugiyama T; Okazaki T; Yabe Y; Suda H; Saito T
Saishin Igaku; 1967 Oct; 22(10):2331-5. PubMed ID: 4871487
[No Abstract] [Full Text] [Related]
12. The prevention of drug-induced retinopathies.
Crews SJ
Trans Ophthalmol Soc U K (1962); 1966; 86():63-76. PubMed ID: 5335103
[No Abstract] [Full Text] [Related]
13. [Chloroquine and ocular disorders].
Kimura R; Nagano S; Watanabe H; Okamura R
Seikei Geka; 1966 Jun; 17(6):468-73. PubMed ID: 6007161
[No Abstract] [Full Text] [Related]
14. [Clinical studies on eye changes during long-term chloroquine therapy].
Pambor R
Dtsch Gesundheitsw; 1968 Dec; 23(50):2383-9. PubMed ID: 5729806
[No Abstract] [Full Text] [Related]
15. Antimalarial treatment of rheumatoid arthritis.
Zvaifler NJ
Med Clin North Am; 1968 May; 52(3):759-64. PubMed ID: 5653948
[No Abstract] [Full Text] [Related]
16. ERG and EOG potentials after 6 years resochin treatment.
Svĕrák J; Erbenová Z; Peregrin J; Salavec M
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1971; 14(2):209-13. PubMed ID: 5289898
[No Abstract] [Full Text] [Related]
17. On very short wavelength electroretinography. An original technique of diagnosis in infraclinical synthetic antimalarial retinopathies.
Alfieri R; Sole P
Ophthalmologica; 1969; 158 Suppl():661-8. PubMed ID: 5359763
[No Abstract] [Full Text] [Related]
18. [Electroretinographic studies on the development of quinine and resochin retinopathies].
Jünemann G; Schulze J
Klin Monbl Augenheilkd; 1968; 152(4):562-6. PubMed ID: 5686094
[No Abstract] [Full Text] [Related]
19. Chloroquin retinopathy.
Chandra RK
Indian J Pediatr; 1967 Jan; 34(228):24-6. PubMed ID: 6037980
[No Abstract] [Full Text] [Related]
20. [The ERG and EOG potentials aft a long-term Resochin therapy].
Svĕrák J; Erbenová Z; Peregrin J; Salavec M
Klin Monbl Augenheilkd; 1970 Sep; 157(3):389-92. PubMed ID: 5486893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
